To overcome the recognised limitations of existing implant technology, NeuroCare aims to develop and test novel, nano-structured, carbon-based prototypes for retinal, cortical and cochlear implants. To achieve such ambitious goals, NeuroCare will specifically focus on:

  • Carbon-biointerface development offering reduced biofouling over the state-of-the-art, as set by the DREAMS project and improved biocompatibility
  • Interfacing of rigid MEAs and FETs with cells and organs to improve bidirectional communication with neurons for in vitro research and pharmacological applications
  • Nanoscale surface engineering and flexible macroscale implant materials for optimal contact to biological tissue
  • Making and testing implantable MEAs and FETs for complex multichannel neuronal communication – targeting the specificity in vivo of the implantable devices for 3 high-impact clinical applications

Comments are closed.